PMI AMEX
Credit Risk of going bust: higher than 98% of companies Debt: 0.1% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.01 (down 99.9%), Picard Medical, Inc. would be worth roughly what it owes.
Total debt $878K against a stock market value of $660.3M.
Distance to default -0.75 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $878K (short-term plus half of long-term), stock volatility 447.4%; Altman Z 31.27. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Tucson, AZ 85713
US
Picard Medical, Inc., through its associated companies, is dedicated to the entire process of medical device commercialization, from initial design and manufacturing to production, distribution, marketing, and sales. A key product in its portfolio is the SynCardia TAH, a sophisticated total artificial heart specifically engineered to supplant a failing human heart in individuals afflicted with advanced cardiac disease. The firm's market presence extends across the United States, Europe, and other international regions. Established in 2021, Picard Medical maintains its primary operations in Tucson, Arizona, functioning as a direct subsidiary of Hunniwell Picard I, Llc.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Skaggs Bernard | 408,956 | $0.71 | 2025-08-28 | |
| Schuster Matt | 68,608 | $0.71 | 2025-08-28 | |
| SCHNEGELSBERG PATRIC | 2,378,124 | $0.71 | 2025-08-28 | |
| Ye George Tiancheng | 0 | — | 2025-08-28 | |
| Van Sam | 0 | — | 2025-08-28 |